Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
We are thrilled to welcome Michael to Avalo’s Board of Directors during this pivotal time in our Company’s growth,” said Dr. Garry Neil, CEO of Avalo Therapeutics. “Michael’s extensive experience in ...